Crystal structure of the piRNA biogenesis factor Zucchini from mouse – Video


Crystal structure of the piRNA biogenesis factor Zucchini from mouse
Animation of X-ray crystallographic structure determined for the protein mZuc (Zucchini / PLD6 from mouse) which has been implicated as a nuclease in piRNA biogenesis. The protein forms a homodimer which displays a narrow, positively-charged groove running through the active site which is capable of accommodating single-stranded nucleic acids. These data are available on the PDB with accession codes 4GGJ and 4GGK. The full research article is: The structural biochemistry of Zucchini implicates it as a nuclease in piRNA biogenesis. Ipsaro JJ, Haase AD, Knott SR, Joshua-Tor L, Hannon GJ. Nature. 2012 Nov 8;491(7423):279-83. doi: 10.1038/nature11502. Epub 2012 Oct 14.

By: jonipsaro

Original post:
Crystal structure of the piRNA biogenesis factor Zucchini from mouse - Video

Biochemists left cell-shocked by UH study

Associate professor Masaya Fujita and doctoral candidate Sarem Davi study B. subtilis cells grown on an agar plate. | File photo/The Daily Cougar

Novel research in UHs biochemistry department is unfolding previously misunderstood and seemingly simple pathways in bacterial sporulation.

Biochemistry associate professor Masaya Fujitaand doctoral candidateSarem Davirecently published a paper in Proceedings of the National Academy of Sciences that outlines a mechanism for spore formation in bacillus subtilis, a common bacteria that is harmless to humans. The pathway was previously assumed by other scientists to involve only one protein: Spo0A. Fujita and Davi discovered that multiple checkpoints were involved that caused this bacteria to form into a spore.

For the bacterial system, people thought it was much simpler than a eukaryotic system. Of course, the eukaryotic systems like our body are very complicated andhave checkpoints or critical points to decide their future fate, Fujita said.

However, B. subtilis undergoes either a growing cell or a spore, depending on the environmental conditions. Its just two choices so people thought that this was very simple: that a single protein Spo0A molecule can make thesedecisions. However, the cells expressing Spo0A only kick off the sporulation process and begin making preparations, but the cells are not yet committed to this survival strategy.

The research was published in the PNAS journal because of the surprise that the previous assumptions were debunked,Fujita said. Instead of a simple network, the process involves many different steps.

The research team found that the ultimate decision process for sporulation is a result of a series of nested feed forward loops network motifs in which one master regulator controls another by directly regulating its amount and indirectly regulating its activity,Fujita said.

Using such integrated and sophisticated genetic networks, the cells can process information, and if needed, change their mind, though without a brain. This strategy allows them to make an accurate decision under unpredictable environmental conditions. Thus, the cells can postpone their final decision-making until the point of no return.

This process is difficult to study with in the wild B. subtilis, Davi said. Artificial techniques needed to be used to study the processes.

Its very difficult to study in the wild-type cells so thats why we use this artificial sporulation system so we can decouple the pathways. We can dissect different pathways and use IPCT as the inducer to study different parts. We can study it in more detail. That is how we can find out that there are different steps going on. Its very complex, Davi said.

More:
Biochemists left cell-shocked by UH study

Odd biochemistry yields lethal bacterial protein

Jan. 22, 2013 While working out the structure of a cell-killing protein produced by some strains of the bacterium Enterococcus faecalis, researchers stumbled on a bit of unusual biochemistry. They found that a single enzyme helps form distinctly different, three-dimensional ring structures in the protein, one of which had never been observed before.

The new findings, reported in Nature Chemical Biology, should help scientists find new ways to target the enterococcal cytolysin protein, a "virulence factor that is associated with acute infection in humans," said University of Illinois chemistry and Institute for Genomic Biology professor Wilfred van der Donk, who conducted the study with graduate student Weixin Tang.

Enterococcus faecalis (EN-ter-oh-cock-us faye-KAY-liss) is a normal microbial inhabitant of the gastrointestinal tracts of humans and other mammals and generally does not harm its host. Some virulent strains, however, produce cytolysin (sigh-toe-LIE-sin), a protein that, once assembled, attacks other microbes and kills mammalian cells.

"The cytolysin protein made by Enterococcus faecalis consists of two compounds that have no activity by themselves but when combined kill human cells," van der Donk said. "We know from epidemiological studies that if you are infected with a strain of E. faecalis that has the genes to make cytolysin, you have a significantly higher chance of dying from your infection." E. faecalis contributes to root canal infections, urinary tract infections, endocarditis, meningitis, bacteremia and other infections.

Enterococcal cytolysin belongs to a class of antibiotic proteins, called lantibiotics, which have two or more sulfur-containing ring structures. Scientists had been unable to determine the three-dimensional structure of this cytolysin because the bacterium produces it at very low concentrations. Another problem that has stymied researchers is that the two protein components of cytolysin tend to clump together when put in a lab dish.

Van der Donk and Tang got around these problems by producing the two cytolysin components separately in another bacterium, Escherichia coli (esh-uh-REE-kee-uh KOH-lie), and analyzing them separately.

"The two components are both cyclic peptides, one with three rings and the other with two rings," van der Donk said. "Curiously, a single enzyme makes both compounds."

In a series of experiments, the researchers found that one ring on each of the proteins adopted a (D-L) stereochemistry that is common in lantibiotics (see image, above). But the other rings all had an unusual (L-L) configuration, something van der Donk had never seen before.

Scientists had assumed that the enzyme that shaped enterococcal cytolysin, a lantibiotic synthetase, acted like a three-dimensional mold that gave the ring structures of cytolysin the exact same stereochemistry, van der Donk said.

"But we found that the enzyme, enterococcal cytolysin synthetase, makes the rings with different stereochemistry," he said. "I don't know of any other examples where one enzyme can make very similar products but with different stereochemistries."

See more here:
Odd biochemistry yields lethal bacterial protein

Study: Odd biochemistry yields lethal bacterial protein

Public release date: 22-Jan-2013 [ | E-mail | Share ]

Contact: Diana Yates diya@illinois.edu 217-333-5802 University of Illinois at Urbana-Champaign

CHAMPAIGN, Ill. While working out the structure of a cell-killing protein produced by some strains of the bacterium Enterococcus faecalis, researchers stumbled on a bit of unusual biochemistry. They found that a single enzyme helps form distinctly different, three-dimensional ring structures in the protein, one of which had never been observed before.

The new findings, reported in Nature Chemical Biology, should help scientists find new ways to target the enterococcal cytolysin protein, a "virulence factor that is associated with acute infection in humans," said University of Illinois chemistry and Institute for Genomic Biology professor Wilfred van der Donk, who conducted the study with graduate student Weixin Tang.

Enterococcus faecalis (EN-ter-oh-cock-us faye-KAY-liss) is a normal microbial inhabitant of the gastrointestinal tracts of humans and other mammals and generally does not harm its host. Some virulent strains, however, produce cytolysin (sigh-toe-LIE-sin), a protein that, once assembled, attacks other microbes and kills mammalian cells.

"The cytolysin protein made by Enterococcus faecalis consists of two compounds that have no activity by themselves but when combined kill human cells," van der Donk said. "We know from epidemiological studies that if you are infected with a strain of E. faecalis that has the genes to make cytolysin, you have a significantly higher chance of dying from your infection." E. faecalis contributes to root canal infections, urinary tract infections, endocarditis, meningitis, bacteremia and other infections.

Enterococcal cytolysin belongs to a class of antibiotic proteins, called lantibiotics, which have two or more sulfur-containing ring structures. Scientists had been unable to determine the three-dimensional structure of this cytolysin because the bacterium produces it at very low concentrations. Another problem that has stymied researchers is that the two protein components of cytolysin tend to clump together when put in a lab dish.

Van der Donk and Tang got around these problems by producing the two cytolysin components separately in another bacterium, Escherichia coli (esh-uh-REE-kee-uh KOH-lie), and analyzing them separately.

"The two components are both cyclic peptides, one with three rings and the other with two rings," van der Donk said. "Curiously, a single enzyme makes both compounds."

In a series of experiments, the researchers found that one ring on each of the proteins adopted a (D-L) stereochemistry that is common in lantibiotics (see image, above). But the other rings all had an unusual (L-L) configuration, something van der Donk had never seen before.

View original post here:
Study: Odd biochemistry yields lethal bacterial protein

Biochemians Got Talent 2012 Awards Ceremony – Video


Biochemians Got Talent 2012 Awards Ceremony
Students created 15 min videos based on any topic / topics from their Level 2 Biochemistry courses. This is a video of the awards ceremony. 1st place: Sweet Assassins youtu.be 2nd place: Say Beta Say Keto youtu.be 3rd place: Ah Bit Ah Oxidation youtu.be Best Fight Scene: The Enzyme League youtu.be Best Song: Say Beta Say Keto youtu.be BiochemJM most popular BGT 2012 video: The Biochemables youtu.be and The Enzyme League youtu.be

By: BiochemJM

View original post here:
Biochemians Got Talent 2012 Awards Ceremony - Video

General Anesthetics – Video


General Anesthetics
www. SalmonellaPlace.com This is a tutorial/lecture on General Anesthetics. We cover some topics important for classes such as Pharmacology, Biochemistry, etc. List of Topics: - Definition of General Anesthesia; - Four Stages of General Anesthesia; - Inhalation Anesthetics; - Intravenous Anesthetics; - Neuroleptic Anesthetics; - Balanced Anesthesia; - Preanesthetic Medication. If you have any questions, don #39;t be shy!! We hope we are able to clarify this topic. Enjoy! Plus, don #39;t forget to SUBSCRIBE for more! Facebook: http://www.facebook.com/salmonellaplace Twitter: http://www.twitter.com/thesalmonella Tumblr: http://www.salmonellaplace.tumblr.com

By: TheSalmonellaPlace

Excerpt from:
General Anesthetics - Video

7.10 – Regenerative Medicine – Video


7.10 - Regenerative Medicine
Speaker: Ms. Elizabeth Sump, Director of Research Administration for the Orthopaedic and Rheumatology Institute, and Director of Governmental Relations, Cleveland Clinic and Dr. Fehmida Kapadia, Research Program Manager, Cleveland Clinic Ms. Sump is the Director of Research Administration for the Orthopaedic and Rheumatology Institute at the Cleveland Clinic, as well as a Director of Government Relations at Cleveland Clinic. She has previously served as the Executive Director of the Clinical Tissue Engineering Center, Chief Commercialization Officer of the Armed Forces Institute of Regenerative Medicine and Vice President of Corporate Development for NetGenics Inc., an enterprise bioinformatics company. A Cleveland native, Ms. Sump has been developing technology for the Healthcare and Life Sciences industries for nearly 25 years. Dr. Kapadia is a Research Program Manager at the Cleveland Clinic responsible for managing product development and commercialization of a device used to identify and isolate stem cells. Dr. Kapadia also manages the research being conducted to develop products for the treatment of wounded warriors as a part of an Armed Forces Institute of Regenerative Medicine research grant. Dr. Kapadia has a PhD in Biochemistry and a Master #39;s in Biotech Entrepreneurship. She has worked for several years in research labs conducting research in cardiovascular and molecular biology. Before joining the Cleveland Clinic, Dr. Kapadia worked at BioEnterprise which is ...

By: NEOinnovates

More here:
7.10 - Regenerative Medicine - Video

Black Swan Avoidance | Dr. McGuff’s “Dirty Dozen” – Video


Black Swan Avoidance | Dr. McGuff #39;s "Dirty Dozen"
Subscribe on Youtube: t21c.com Subscribe by e-mail: http://www.the21convention.com Follow on Twitter twitter.com About : Doug McGuff, MD became interested in exercise at the age of 15 when he first read Arthur Jones #39; Nautilus Training Bulletin No. 2. His interest in exercise and biology led him into a career in medicine. In 1989, he graduated from the University of Texas Medical School at San Antonio and went on to train in Emergency Medicine at the University of Arkansas for Medical Sciences at Little Rock where he served as Chief Resident. From there, Dr. McGuff served as Faculty in the Wright State University Emergency Medicine Residency and was a staff Emergency Physician at Wright-Patterson AFB Hospital. Throughout his career Dr. McGuff maintained his interest in high intensity exercise. Doug realized a lifelong dream when he opened Ultimate Exercise in November, 1997. Over the past 13 years Dr. McGuff and his instructors have continued to explore the limits of exercise through their personal training clients at Ultimate Exercise. In addition to his work at Ultimate Exercise, Dr. McGuff is a partner with Blue Ridge Emergency Physicians, PA Dr. McGuff Lives in Seneca, South Carolina with his wife of 25-years, and their Children Eric and Madeline. Doug is the best selling co-author of Body by Science ( amzn.to ) and The Body by Science Question and Answer Book ( amzn.to ). Visit Doug #39;s blog at http://www.bodybyscience.net See Doug #39;s first lecture at The 21 Convention here on the ...

By: Under21convention07

Read the rest here:
Black Swan Avoidance | Dr. McGuff's "Dirty Dozen" - Video

Tutorial on Chemical Bonds – Video


Tutorial on Chemical Bonds
http://www.ScienceTutorOnline.com This week I #39;m doing a tutorial on chemical bonds, and really on the importance of valence electrons. Covalent bonds and ionic bonds are important because they determine the properties of many compounds. Hydrogen bonds play a role in the structure and function of DNA, as well as the ability for many proteins to bind with receptors. There #39;s a little bit in here about electronegativity and the redox reactions because these concepts are important for biochemistry, and I mention the Van der Waals effect because it #39;s just that cool. I do a new science tutor video every Monday night, in case you want to subscribe. Or you can get a lot of goodies (including help on your science homework, of course), by going to my website at http If you #39;re not already comfortable with electron shells and orbitals, I suggest you watch another video first, which you can find at this link: sciencetutoronline.com

By: ScienceTutorOnline

View original post here:
Tutorial on Chemical Bonds - Video

RHODES UNIVERSITY: Biotechnology unit ‘surprises with its skills’

THE danger for South Africa is that we are in competition with everyone in the world of biotechnology, says Janice Limson, head of Rhodes Universitys biotechnology unit. "But the thing with innovation is that a hit can come from anywhere."

The university has a school of biochemistry, microbiology and biotechnology, and it has impressive credentials: "Rhodes was the home of biotechnology in South Africa, with the first postgraduate biotechnology (course) in the country."

However, the university "needs to create an enabling space to move into industry There is a new generation of academics who want to innovate and do work that can make an impact Its pointless if we dont engage in technology transfer and showcase biotechnology."

Her research focuses on sensors. "We create a special sensing solution for specific targets: an electrochemical sensor using biological recognition agents, such as antibodies and enzymes."

Glucose tests are a form of biosensor, used by patients to check their blood-sugar levels. "Biomedical sensors is a multibillion-dollar industry," she says.

Her group is working on breast cancer detectors. "(You) can send (the sensor solution) into the body and label the (cancer cells) in some way that can be targeted and couple that with a drug. The sensor goes to the target and then delivers a drug at the same time," Dr Limson says.

She notes that developing biomedical technologies is difficult without a medical school. "But there is scope for fundamental research which can be readily applied," she says.

Tebello Nyokong, director of the Nanotechnology Innovation Centre hosted by the university, was once Dr Limsons PhD supervisor. She is not concerned that her centre is so far from the nearest medical school: "We are not dealing with patients, so it is okay with me. The government does not allow researchers to touch patients."

Prof Nyokong one of the top scientists in South Africa and winner of the 2009 LOreal-Unesco award for women in science is working on a cancer treatment which is activated by light.

She focuses on skin cancer: "You apply the drug to the skin, and you just need sunlight," she says, adding that it is important to get through all the red tape as quickly as possible because HIV/AIDS "results in a lot of people dying from skin cancer".

Go here to read the rest:
RHODES UNIVERSITY: Biotechnology unit ‘surprises with its skills’

ALL FULL-BODY – Fat Burning Circuit Workout – Video


ALL FULL-BODY - Fat Burning Circuit Workout
For more Fat Burning workouts: howgainmuscle.org For more Fat Burning workouts and exercises for a tight butt, round butt and sexy legs join my free newsletter for all my up-to-date exercises for women and workouts for women: howgainmuscle.org Here is the breakdown of my circuit workout. Grab some water because this is a KILLER workout that will help you burn a ton of calories. Exercise 1: Front Squat x 12 Exercise 2: Squat with Lateral Leg Raise x 15/side Exercise 3: Resistance Band Lateral Side Step x 20/side Exercise 4: Chin-up - failure Exercise 5: Push-up x 12 Exercise 6: Mountain Climbers - 30 seconds 5 Killer Butt Exercises For A Tight And Round Butt - For more info on butt exercises visit my website: Considering that I #39;d a busy full time job, I failed to make time for sports activities and since I did not know something about currently being a conditioning product. I obtained 15 kilos of excessive fat, primarily all around my mid-section. My husband suggests I could have been the confront for "Flabbily Fitness" if I did not alteration my means. I had been 24 and Tolley with the initial time in my life and hardly ever dreamed of getting a exercise design body. It had been certainly depressing. I realized I desired a modify. I joined a gymnasium and hired a private coach to master the best most women routines as I used to be intimidated by weights and the many devices for feminine conditioning. I misplaced 12 lbs inside of the primary thirty day period of doing the ...

By: Flavia Workouts

Read more from the original source:
ALL FULL-BODY - Fat Burning Circuit Workout - Video

21 Days: Wellness – Day 10 – Soda, Don’t Drink It – Video


21 Days: Wellness - Day 10 - Soda, Don #39;t Drink It
http://www.ocnewlife.org 21 Days Wellness - Day 10 - Soda, Don #39;t Drink It - Coach Lana Welcome to 21 Days for Change. I #39;m Coach Lana and today we are talking about, soda. Don #39;t drink it. I could go on for an inappropriate amount of time on this one. In fact I #39;ve done 2 separate videos just on Soda. So, this is the short list of why you want to cut it from your diet. On a scale of 1-10. 1 the food could possibly kill you, 10 the food will lengthen your life. Soda is probably a 2-3. Jillian Michaels would probably argue it #39;s a 1-2. The first ingredient in soda is usually high fructose corn syrup which has been linked to diabetes, heart disease, cancer, and on and on.. Even diet soda has been found to mess with your hormones and biochemistry, making it harder for your body to know when it #39;s full. The brown color in soda has also been linked to cancer. And there is so much more. Yikes! Soda is a pleasure food. It #39;s not necessary so cutting back, may be hard, but it #39;s good for us. If you struggle with this, I highly recommend going to http://www.doctoroz.com and looking up 28 day national soda challenge. It has easy baby steps for you to take. http://www.doctoroz.com If this is an area you struggle with, ask Jesus to help you. Believe this is not too small for Him to tackle with you. I hope to talk with you again tomorrow. Thanks for watching.

By: OCNewLife

See more here:
21 Days: Wellness - Day 10 - Soda, Don't Drink It - Video

Promising new target for Parkinson’s disease identified

Washington, January 19 (ANI): Researchers including one of Indian origin have identified a novel target for treating Parkinson's disease.

Narayan G. Avadhani, Harriet Ellison Woodward Professor of Biochemistry and chair of the Department of Animal Biology at the University of Pennsylvania School of Veterinary Medicine, was the senior author on the research.

To study Parkinson's, researchers have commonly mimicked the effects of the disease in animals by giving them a compound known as MPTP, a contaminant of the illicit drug MPPP, or synthetic heroin. MPTP causes damage to brain cells that respond to the neurotransmitter dopamine, leading to problems in muscle control, including tremors and difficulty walking.

The common understanding of MPTP's mechanism was that it entered the brain and was eventually converted to the toxic compound MPP+ by the enzyme MAO-B, which is located on the mitochondria of non-dopaminergic (or dopamine-sensitive) neurons. Scientists believed MPP+ was carried by the action of specific transporters into dopaminergic neurons, where it inhibited mitochondrial function and led to cell death.

In the new study, the Penn-led team turned its attention to yet another molecule, known as mitochondrial CYP2D6, which until recently has been largely uninvestigated. Previous studies in the investigators' laboratory showed that CYP2D6, a protein that is predominantly localized to cells' endoplasmic reticulum, was also targeted to their mitochondria.

Unlike MAO-B, the endoplasmic reticulum-associated CYP2D6 was thought to have a protective effect against MPTP toxicity. The authors now show that mitochondrial CYP2D6 can effectively metabolize MPTP to toxic MPP+, indicating a possible connection between mitochondrial CYP2D6 and Parkinson's.

"About 80 percent of the human population has only one copy of CYP2D6, but the other 20 percent has variant forms of it and some populations have multiple copies. In those people, the activity of mitochondrial CYP2D6 can be high, and there have been correlations between these variants and the incidence of Parkinson's disease," Avadhani said.

Working with primary neuronal cells in culture, the researchers showed that mitochondrial CYP2D6 could actively oxidize MPTP to MPP+. When they introduced compounds that selectively inhibited the activity of CYP2D6, this conversion process was largely halted. Neuronal degeneration was also greatly reduced.

"If we add MPTP to dopamine-sensitive neurons and also add a CYP2D6 inhibitor, we see marked protection of the neuronal function. We believe this is a paradigm shift in how we think about the mechanism of Parkinson's," Avadhani said.

A number of MAO-B inhibitors used in the clinical setting for treating Parkinson's disease have unwanted side effects. A mitochondrial CYP2D6 inhibitor represents a much more specific and direct target and may thus cause fewer troublesome side effects.

Continue reading here:
Promising new target for Parkinson's disease identified

OSU professor teaches biochemistry with limericks and song

Sing a Song of Science (video) Kevin Ahern, a bio-chemistry professor at Oregon State University, uses song to help his classes to learn complicated science data. Now he teaches a class, "Sing a Song of Science," that teaches honors students how to do the same. Watch video On Tuesday afternoons in a small upstairs classroom, Kevin Ahern blows the stiff-collared stereotype of science academia to bits.

Ahern, a biochemistry instructor and director of undergraduate research at Oregon State University, doesn't consider it disruptive to break out in song during class. On the contrary, the songs become the subject matter on Tuesdays, when he teaches the class "Sing a Song of Science" to a dozen honors students. Limericks

"Music brings back memories," he tells the group of future veterinarians, philosophers and doctors before pressing play on a recording of the Alphabet Song.

All the students smile in recognition.

"See, that's literally how 95 percent of kids in this country learn their ABCs," Ahern says. "I took a little different direction."

He presses play again, and a new version of the song begins. Instead of the letters of the alphabet, they hear a ditty that lists amino acids.

Lysine, arginine and his Basic ones you should not miss Ala, leu, val, ile and met Fill the aliphatic set

These are honors students at a major university, and they're singing along to a re-imagined children's song.

It's not a typical scenario for an advanced biochemistry course, but Ahern is not your typical biochemistry professor. The nutty professor

Ahern, a self-described nerd, doesn't limit his quirkiness to science. He's a real-life nutty professor known for his creative streak and is just as comfortable with the dry language of science as he is with the melody and cadence of a '60s pop song.

See the article here:
OSU professor teaches biochemistry with limericks and song

UMD chemistry and biochemistry department receives NSF funding

DARTMOUTH Researchers in the chemistry and biochemistry department at the University of Massachusetts Dartmouth recently received a $339,000 Major Research Instrument award for the acquisition of a 400 MHz Nuclear Magnetic Resonance spectrometer, a primary means of characterizing chemical structures.

The spectrometer represents a big step forward in the department's ability to perform research, train students and attract new faculty. From researching botulism antidotes to studying the health effects of cranberries, this instrument will impact nearly all chemistry and biochemistry projects, the university said.

Dr. Bal Ram Singh, director of the Botulinum Research Center, will use the spectrometer to determine the structure of botulism antidotes being developed from natural compound libraries, while Dr. Sivappa Rasapalli will use it for method development in organic synthesis. In his work, Rasapalli looks for new ways to produce natural products and their derivatives as potential pharmaceuticals.

The spectrometer will also facilitate the work of Dr. David Manke, who will use the NMR to characterize inorganic compounds his lab produces. Specifically, his lab synthesizes inorganic molecules and solids to be applied to the capture and activation of carbon dioxide.

The spectrometer will benefit two professors conducting cranberry health research. Dr. Catherine Neto, director of the Cranberry Health Research Center, will use the NMR to characterize cranberry plant compounds that have potential use as antimicrobials, antioxidants and anti-cancer agents. Dr. Maolin Guo, co-director of the Cranberry Health Research Center, will use the spectrometer to characterize molecular imaging sensors developed in his lab that can study the activity of cranberry antioxidants in live cells.

The instrument will also be useful for several other faculty members including Dr. Brian Dixon at the Massachusetts Maritime Academy.

The award was granted under the leadership of principal investigator Maolin Guo and co-principal investigators David Manke, Catherine Neto, Emmanuel Ojadi and Sivappa Rasapalli.

The rest is here:
UMD chemistry and biochemistry department receives NSF funding